Unknown

Dataset Information

0

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.


ABSTRACT: C-X-C chemokine receptor 4 (CXCR4) is over-expressed in multiple human cancers and correlates with tumor aggressiveness, poor prognosis and increased risk for distant metastases. Imaging agents for CXCR4 are thus highly desirable. We developed a novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) conjugating the new developed CXCR4 peptidic antagonist Peptide R with the NIR fluorescent dye VivoTag-S750. Specific CXCR4 binding was obtained in cells overexpressing human CXCR4 (B16-hCXCR4 and human melanoma cells PES43), but not in CXCR4 low expressing cells (FB-1). Ex vivo evaluation demonstrated that PepR-NIR750 specifically detects B16-hCXCR4-derived subcutaneous tumors and lung metastases. Fluorescence Molecular Tomography (FMT) in vivo imaging was performed on mice carrying subcutaneous CHO and CHO-CXCR4 tumors. PepR-NIR750 accumulates only in CXCR4-positive expressing subcutaneous tumors. Additionally, an intense NIR fluorescence signal was detected in PES43-derived lung metastases of nude mice injected with PepR-NIR750 versus mice injected with VivoTag-S750. With a therapeutic intent, mice bearing PES43-derived lung metastases were treated with Peptide R. A the dramatic reduction in PES43-derived lung metastases was detected through a decrease of the PepR-NIR750 signal. PepR-NIR750 is a specific probe for non-invasive detection of human high CXCR4-expressing tumors and metastatic lesion and thus a valuable tool for cancer molecular imaging.

SUBMITTER: Santagata S 

PROVIDER: S-EPMC5451476 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.

Santagata Sara S   Portella Luigi L   Napolitano Maria M   Greco Adelaide A   D'Alterio Crescenzo C   Barone Maria Vittoria MV   Luciano Antonio A   Gramanzini Matteo M   Auletta Luigi L   Arra Claudio C   Zannetti Antonella A   Scala Stefania S  

Scientific reports 20170531 1


C-X-C chemokine receptor 4 (CXCR4) is over-expressed in multiple human cancers and correlates with tumor aggressiveness, poor prognosis and increased risk for distant metastases. Imaging agents for CXCR4 are thus highly desirable. We developed a novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) conjugating the new developed CXCR4 peptidic antagonist Peptide R with the NIR fluorescent dye VivoTag-S750. Specific CXCR4 binding was obtained in cells overexpressing human C  ...[more]

Similar Datasets

| S-EPMC5452499 | biostudies-literature
| S-EPMC2912453 | biostudies-literature
| S-EPMC5885141 | biostudies-literature
| S-EPMC8148031 | biostudies-literature
| S-EPMC6987190 | biostudies-literature
| S-EPMC6900745 | biostudies-literature
| S-EPMC3213350 | biostudies-literature
| S-EPMC9612122 | biostudies-literature
| PRJEB51223 | ENA
| S-EPMC3201797 | biostudies-literature